Convergent evolution in SARS-CoV-2 Spike creates a variant soup that causes new COVID-19 waves.
Focosi, D.; Quiroga, R.; McConnell, S.; Johnson, M. C.; Casadevall, A.
Show abstract
The first 2 years of the COVID-19 pandemic were mainly characterized by convergent evolution of mutations of SARS-CoV-2 Spike protein at residues K417, L452, E484, N501 and P681 across different variants of concern (Alpha, Beta, Gamma, and Delta). Since Spring 2022 and the third year of the pandemic, with the advent of Omicron and its sublineages, convergent evolution has led to the observation of different lineages acquiring an additional group of mutations at different amino acid residues, namely R346, K444, N450, N460, F486, F490, Q493, and S494. Mutations at these residues have become increasingly prevalent during Summer and Autumn 2022, with combinations showing increased fitness. The most likely reason for this convergence is the selective pressure exerted by previous infection- or vaccine-elicited immunity. Such accelerated evolution has caused failure of all anti-Spike monoclonal antibodies, including bebtelovimab and cilgavimab. While we are learning how fast coronaviruses can mutate and recombine, we should reconsider opportunities for economically sustainable escape-proof combination therapies, and refocus antibody-mediated therapeutic efforts on polyclonal preparations that are less likely to allow for viral immune escape.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting. 96%
- Assessing bnAb potency in the context of HIV-1 Envelope conformational plasticity 95%
- Variant-specific humoral immune response to SARS-CoV-2 escape mutants arising in clinically severe, prolonged infection 94%
Similar papers in this journal
- SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity 94%
- Origins and Evolution of Seasonal Human Coronaviruses 93%
- The spread of SARS-CoV-2 variant Omicron with the doubling time of 2.0–3.3 days can be explained by immune evasion 93%
Similar papers in this journal
- SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay 93%
- Live virus neutralisation testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2 92%
- Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients 92%
Similar papers in this journal
- The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody 94%
- Spread of endemic SARS-CoV-2 lineages in Russia 93%
- Increasing SARS-CoV-2 mutations against vaccination-acquired immunity 92%
Similar papers in this journal
- Neutralization of SARS-CoV-2 variants by rVSV-ΔG-spike-elicited human sera 94%
- The rise and fall of an emerging SARS-CoV-2 variant with the spike protein mutation L452R 93%
- Increased receptor affinity and reduced recognition by specific antibodies contribute to immune escape of SARS-CoV-2 variant Omicron 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.